Wolfe Research Downgrades RXO to Underperform, Announces $19 Price Target
Portfolio Pulse from richadhand@benzinga.com
Wolfe Research analyst Scott Group has downgraded RXO (NYSE:RXO) from Peer Perform to Underperform and set a price target of $19.
July 12, 2023 | 11:53 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
RXO has been downgraded to Underperform by Wolfe Research with a price target of $19.
The downgrade from Peer Perform to Underperform by Wolfe Research indicates a negative outlook for RXO. The price target of $19 also suggests that the analyst believes the stock is currently overvalued. This could lead to a decrease in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100